AbstractThe crystallographic structure of human coagulation factor VIIa/tissue factor complex bound with calcium ions was used to model the solution structure of the light chain of factor VIIa (residues 1–142) in the absence of tissue factor. The Amber force field in conjunction with the particle mesh Ewald summation method to accommodate long-range electrostatic interactions was used in the trajectory calculations. The estimated TF-free solution structure was then compared with the crystal structure of factor VIIa/tissue factor complex to estimate the restructuring of factor VIIa due to tissue factor binding. The solution structure of the light chain of factor VIIa in the absence of tissue factor is predicted to be an extended domain struc...
In the blood coagulation pathway the zymogen factor X (FX) is converted to its enzymatic form (FXa) ...
A solution structure for the complete zymogen form of human coagulation protein C is modeled. The in...
AbstractA solution structure for the complete zymogen form of human coagulation protein C is modeled...
AbstractThe crystallographic structure of human coagulation factor VIIa/tissue factor complex bound ...
The crystallographic structure of human coagulation factor VIIa/tissue factor complex bound with cal...
<p>Tissue factor (TF)-mediated factor VII (FVII) activation and a subsequent proteolytic TF-FVIIa bi...
AbstractThe four-domain structure of human factor VIIa and the two-domain structure of tissue factor...
AbstractFactorVIIa (fVIIa) consists of a heavy chain (serine protease domain) and a light chain (γ-c...
AbstractAs an attempt to investigate the dynamic interactions between plasma serine protease, coagul...
The putative structure of the Tissue Factor/Factor VIIa/Factor Xa (TF/FVIIa/FXa) ternary complex is ...
Factor VIIa (EC 3.4.21.21) is a trypsin-like serine protease that plays a key role in the blood coag...
AbstractThe solution structure and dynamics of the human coagulation factor X (FX) have been investi...
The solution structure and dynamics of the human coagulation factor X (FX) have been investigated to...
International audienceUpon binding to tissue factor, FVIIa triggers coagulation by activating vitami...
Blood coagulation factor VIIa (FVIIa) is used in the treatment of replacement therapy resistant hemo...
In the blood coagulation pathway the zymogen factor X (FX) is converted to its enzymatic form (FXa) ...
A solution structure for the complete zymogen form of human coagulation protein C is modeled. The in...
AbstractA solution structure for the complete zymogen form of human coagulation protein C is modeled...
AbstractThe crystallographic structure of human coagulation factor VIIa/tissue factor complex bound ...
The crystallographic structure of human coagulation factor VIIa/tissue factor complex bound with cal...
<p>Tissue factor (TF)-mediated factor VII (FVII) activation and a subsequent proteolytic TF-FVIIa bi...
AbstractThe four-domain structure of human factor VIIa and the two-domain structure of tissue factor...
AbstractFactorVIIa (fVIIa) consists of a heavy chain (serine protease domain) and a light chain (γ-c...
AbstractAs an attempt to investigate the dynamic interactions between plasma serine protease, coagul...
The putative structure of the Tissue Factor/Factor VIIa/Factor Xa (TF/FVIIa/FXa) ternary complex is ...
Factor VIIa (EC 3.4.21.21) is a trypsin-like serine protease that plays a key role in the blood coag...
AbstractThe solution structure and dynamics of the human coagulation factor X (FX) have been investi...
The solution structure and dynamics of the human coagulation factor X (FX) have been investigated to...
International audienceUpon binding to tissue factor, FVIIa triggers coagulation by activating vitami...
Blood coagulation factor VIIa (FVIIa) is used in the treatment of replacement therapy resistant hemo...
In the blood coagulation pathway the zymogen factor X (FX) is converted to its enzymatic form (FXa) ...
A solution structure for the complete zymogen form of human coagulation protein C is modeled. The in...
AbstractA solution structure for the complete zymogen form of human coagulation protein C is modeled...